Mercky waters

Article Abstract:

Merck traditionally has been the leader in the pharmaceutical industry, but its insistence on continuing to do its own research in a time of biotechnology and genetics has caused some observers to question the company's tactics. Merck recorded a net profit of $3.9 billion in 1996.

Planning, Pharmaceutical research, Merck & Company Inc.

---

Too clever by half; even drug firms with first-class research need the business basics

Article Abstract:

Research indicates that pharmaceutical companies could boost their profits by as much as 75% by improving their marketing and supply-chain management. Price-competition is likely to force drug companies to focus less on developing breakthrough drugs and more on business basics.

---

Japan's sickly drug firms

Article Abstract:

Japan's health ministry is increasing its efforts to reduce drug prices and prevent the over-prescription of drugs in an effort to makes its floundering pharmaceutical industry more competitive. The reforms are expected to reduce the pharmaceuticals market by 25%.

Japan, Economic policy

Similar abstracts:

• Abstracts: Project selection with discounted returns and multiple constraints. Stock cutting to minimize cutting length
• Abstracts: The die is cast: enclave is already surrendering to China's embrace
• Abstracts: Hierarchical versus other market share models for markets with many items. Estimating and validating asymmetric heterogeneous loss functions applied to health care fund raising
• Abstracts: Enlisting Asean's help with Burma. Prosecute the Khmer Rouge killers. Asean can promote democracy in Burma
• Abstracts: Portable CD players handle slopes with more grace than a reporter. Like the Democrats, but lack citizenship? Aid the campaign, virtually, on the Web

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.